Screening method for proteinuria component induced renal interstitial fibrosis based on micro-fluidic chip
A microfluidic chip and chip technology, applied in the field of biomedical research, can solve the problems of high cost of treatment, heavy economic burden on individuals and society, and achieve the effect of reducing consumption
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] First carry out HK-2 cell inoculation:
[0038] After human proximal tubular epithelial cells (HK-2) were digested, fresh culture medium was added to adjust the cell density to 1×10 6 / ml, pipette the cell suspension into figure 1 In the central pool of the chip shown, when the cells are observed to flow into the cell culture chamber under the action of the hydrostatic fluid, 5-10ml of fresh culture solution is quickly covered on the surface of the chip, and the HK-2 cells in the chip stop flowing immediately, due to Due to the settling effect of the cells' own gravity, the cells can quickly stop in the cell culture room, put the chip into a 37°C incubator for static culture, take out the chip after about 30min-2h, absorb the excess culture solution on the surface of the chip, and then Then put the chip back into the 37°C incubator to continue culturing.
[0039] Then add the inducing factor: connect the central pool and the syringe pump through the tetrafluoro tube, ...
Embodiment 2
[0043] HK-2 cell inoculation and staining steps are the same as "Example 1"
[0044] Complement C3a is an important component factor in the complement system. According to the existing experimental results in "Example 1", complement C3a is added here for further investigation.
[0045] The specific inducing factor adding process is as follows: connect the central pool and the syringe pump through the tetrafluoro tube, turn on the syringe pump, adjust the flow rate to 0.6 μl / min, and sequentially add the same volume of inducing factors from the stimulant inlet pool: 1- 3 did not add any stimulating factors, as a negative control group; 4-6 respectively added 2.5ng / ml, 5ng / ml, 10ng / ml transforming growth factor (transforming growth factor-β, TGF-β), as a positive control group; 7-9 respectively added the mixture containing different concentrations (1%, 3%, 5%) of ihhs and complement C3a (10nM); 10-12 respectively added 1%, 3%, 5% inactivated healthy human serum ( inactive human...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com